UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 135

Sortiert nach

Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter

ACS nano, 2014-01, Vol.8 (1), p.483-494

2014

Volltextzugriff (PDF)

Viral vectors for therapy of neurologic diseases

Neuropharmacology, 2017-07, Vol.120, p.63-80

2017

Volltextzugriff (PDF)

High levels of AAV vector integration into CRISPR-induced DNA breaks

Nature communications, 2019-09, Vol.10 (1), p.4439-11, Article 4439

2019

Volltextzugriff (PDF)

Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation

Human molecular genetics, 2020-10, Vol.29 (17), p.2920-2935

2020

Volltextzugriff (PDF)

Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV

Molecular therapy, 2017-02, Vol.25 (2), p.379-391

2017

Volltextzugriff (PDF)

Heparin affinity purification of extracellular vesicles

Scientific reports, 2015-05, Vol.5 (1), p.10266-10266, Article 10266

2015

Volltextzugriff (PDF)

Trafficking of adeno‐associated virus vectors across a model of the blood–brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells

Journal of neurochemistry, 2017-01, Vol.140 (2), p.216-230

2017

Volltextzugriff (PDF)

AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response

Molecular oncology, 2020-11, Vol.14 (11), p.2920-2935

2020

Volltextzugriff (PDF)

Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo

Biomaterials, 2014-08, Vol.35 (26), p.7598-7609

2014

Volltextzugriff (PDF)

Microvesicle-associated AAV Vector as a Novel Gene Delivery System

Molecular therapy, 2012-05, Vol.20 (5), p.960-971

2012

Volltextzugriff (PDF)

Heparin blocks transfer of extracellular vesicles between donor and recipient cells

Journal of neuro-oncology, 2013-12, Vol.115 (3), p.343-351

2013

Volltextzugriff (PDF)

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

Molecular therapy. Nucleic acids, 2018-06, Vol.11 (C), p.429-440

2018

Volltextzugriff (PDF)

Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety

International journal of molecular sciences, 2022-01, Vol.23 (2), p.819

2022

Volltextzugriff (PDF)

BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles

Molecular therapy. Nucleic acids, 2013, Vol.2 (7), p.e109-e109, Article e109

2013

Volltextzugriff (PDF)

Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate

Molecular therapy. Methods & clinical development, 2019-06, Vol.13, p.1-13

2019

Volltextzugriff (PDF)

Selection of an Efficient AAV Vector for Robust CNS Transgene Expression

Molecular therapy. Methods & clinical development, 2019-12, Vol.15, p.320-332

2019

Volltextzugriff (PDF)

In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery

Scientific reports, 2020-03, Vol.10 (1), p.4544-4544, Article 4544

2020

Volltextzugriff (PDF)

Accessorizing viral vectors with extracellular vesicles for enhanced performance

Molecular therapy, 2023-05, Vol.31 (5), p.1204-1206

Maguire, Casey A.

2023

Volltextzugriff (PDF)

Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65

Molecular therapy. Methods & clinical development, 2018-09, Vol.10, p.197-209

2018

Volltextzugriff (PDF)

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear

Molecular therapy. Methods & clinical development, 2021-06, Vol.21, p.382-398

2021

Volltextzugriff (PDF)

An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction

Molecular therapy. Methods & clinical development, 2023-06, Vol.29, p.532-540

2023

Volltextzugriff (PDF)

Extracellular vesicles and intercellular communication within the nervous system

The Journal of clinical investigation, 2016-04, Vol.126 (4), p.1198-1207

2016

Volltextzugriff (PDF)

Gaussia Luciferase Variant for High-Throughput Functional Screening Applications

Analytical chemistry (Washington), 2009-08, Vol.81 (16), p.7102-7106

2009

Volltextzugriff (PDF)

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Molecular therapy. Methods & clinical development, 2022-09, Vol.26, p.169-180

2022

Volltextzugriff (PDF)

Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9

Molecular therapy. Methods & clinical development, 2016-01, Vol.3 (C), p.16081-16081, Article 16081

2016

Volltextzugriff (PDF)

1 – 25 von 135

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(121)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(135)
Japanisch
(19)

Erscheinungsjahr

n.n

Thema

Science & Technology
(88)
Life Sciences & Biomedicine
(70)
Humans
(47)
Animals
(38)
Medicine, Research & Experimental
(32)
Research & Experimental Medicine
(32)
Gene Therapy
(31)
Mice
(25)
Dependovirus - Genetics
(18)
Genetics & Heredity
(17)
Male
(17)
Biotechnology & Applied Microbiology
(16)
Gene Transfer Techniques
(15)
Genetic Vectors - Genetics
(15)
Genomes
(15)
Transduction, Genetic
(15)
Adeno-Associated Virus
(14)
Neurosciences
(14)
Gene Expression
(12)
Gene Transfer
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dynamic Biodistribution of Extracellular Vesicles in Vivo Using a Multimodal Imaging Reporter

Viral vectors for therapy of neurologic diseases

High levels of AAV vector integration into CRISPR-induced DNA breaks

Gene therapy for Alzheimer’s disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation

Rescue of Hearing by Gene Delivery to Inner-Ear Hair Cells Using Exosome-Associated AAV

Heparin affinity purification of extracellular vesicles

Trafficking of adeno‐associated virus vectors across a model of the blood–brain barrier; a comparative study of transcytosis and transduction using primary human brain endothelial cells

AAV‐mediated gene transfer of DNase I in the liver of mice with colorectal cancer reduces liver metastasis and restores local innate and adaptive immune response

Naturally enveloped AAV vectors for shielding neutralizing antibodies and robust gene delivery in vivo

Microvesicle-associated AAV Vector as a Novel Gene Delivery System

Heparin blocks transfer of extracellular vesicles between donor and recipient cells

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease

Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety

BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles

Gene Transfer with AAV9-PHP.B Rescues Hearing in a Mouse Model of Usher Syndrome 3A and Transduces Hair Cells in a Non-human Primate

Selection of an Efficient AAV Vector for Robust CNS Transgene Expression

In vivo engineering of lymphocytes after systemic exosome-associated AAV delivery

Accessorizing viral vectors with extracellular vesicles for enhanced performance

Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear

An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction

Extracellular vesicles and intercellular communication within the nervous system

Gaussia Luciferase Variant for High-Throughput Functional Screening Applications

Gene replacement therapy in a schwannoma mouse model of neurofibromatosis type 2

Tailored transgene expression to specific cell types in the central nervous system after peripheral injection with AAV9

Suchergebnisse filtern